Connors Investor Services’s Cellebrite CLBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.57M Sell
175,767
-75,818
-30% -$1M 0.22% 85
2026
Q1
$3.47M Buy
251,585
+11,292
+5% +$170K 0.32% 62
2025
Q4
$4.33M Sell
240,293
-5,496
-2% -$98.7K 0.37% 55
2025
Q3
$4.55M Buy
245,789
+65,479
+36% +$1.03M 0.39% 51
2025
Q2
$2.88M Buy
180,310
+37,870
+27% +$675K 0.26% 69
2025
Q1
$2.77M Sell
142,440
-1,181
-0.8% -$24.9K 0.27% 65
2024
Q4
$3.16M Sell
143,621
-2,414
-2% -$46.5K 0.3% 68
2024
Q3
$2.46M Sell
146,035
-4,819
-3% -$71.5K 0.24% 79
2024
Q2
$1.8M Buy
+150,854
New +$1.69M 0.19% 86

Other funds holding CLBT

Connors Investor Services's CLBT Position: Q2 2026 in Review

Connors Investor Services reduced its Cellebrite (CLBT) stake by 30% in Q2 2026, selling an estimated $1M and leaving 175,767 shares worth $2.57M. The position accounts for 0.22% of the portfolio, ranked #85.

Connors Investor Services first reported a position in CLBT in Q2 2024 and has held it in 9 quarters since. The position peaked at $4.55M in Q3 2025. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • Connors Investor Services held 175,767 shares of Cellebrite worth $2.57M as of Q2 2026.
  • Connors Investor Services sold 75,818 Cellebrite shares in Q2 2026, an estimated $1M.
  • Cellebrite made up 0.22% of Connors Investor Services's portfolio in Q2 2026, its #85 holding.
  • Connors Investor Services first reported a position in Cellebrite in Q2 2024 and has held it in 9 quarters since.
  • Connors Investor Services's Cellebrite position peaked at $4.55M in Q3 2025.
  • 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on Connors Investor Services's 13F filing for Q2 2026, filed 14 Aug 2026.